Phage therapy is a treatment using viruses, called bacteriophages, able to attack specifically bacteria and destroy them with complete harmlessness for human cells. The PHAG-ONE project is one of the 11 projects selected as part of the call for projects "Antibiotic resistance: understand, innovate, act" led by the National Research Agency (ANR). This priority research program was launched by the government, under the aegis of the General Secretariat for Investment and the ANR, as part of the Future Investment Programs.
Click to learn more about Work Packages
March 2025
24
25
26
27
28
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
HCL: two unprecedented victories against antibiotic resistance
Why HCL invest in phage therapy?
In Lyon, the HCL are developing viruses to fight against resistant bacteria
Facing antibiotic resistance: a political ecology of microbes
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection 02/11/2021 Evaluation of the Activity of the Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts 21/02/2020